Survival analysis TSD
A review of methods for undertaking survival analysis for use in an economic evaluation when patient-level data are available and evidence synthesis is not necessary, with recommendations on systematic processes.
TSD 14 one page summary (PDF, 102KB)
N Latimer (2013) Survival analysis for economic evaluations alongside clinical trials – extrapolation with patient-level data. Inconsistencies, limitations, and a practical guide. Medical Decision Making, 33 (6), pp. 743-754. DOI: https://doi.org/10.1177/0272989x12472398
A Bagust, S Beale (2013) Survival analysis and extrapolation modeling of time-to-event clinical trail data for economic evaluation: an alternative approach. Medical Decision Making, 34(3), pp.343–351. DOI: https://doi.org/10.1177/0272989X13497998
N Latimer (2013) Response to “Survival analysis and extrapolation modeling of time-to-event clinical trial data for economic evaluation: an alternative approach” by Bagust and Beal. Medical Decision Making, 34(3), pp. 279–282. DOI: https://doi.org/10.1177/0272989X13511302
A global reputation
Sheffield is a research university with a global reputation for excellence. We're a member of the Russell Group: one of the 24 leading UK universities for research and teaching.